Joint safety and neurologic events with subcutaneous tanezumab or oral nonsteroidal anti-inflammatory drugs in subgroups of patients with osteoarthritis from an 80-week phase 3 study

Saved in:
Bibliographic Details
Published inOsteoarthritis and cartilage Vol. 29; pp. S246 - S247
Main Authors Hunter, D.J., Radominski, S., Rodriguez Ulloa, S., Goranov, I., Radunovic, G., Chang, C., Pixton, G., Hickman, A., Fountaine, R.J., Brown, M.T., Viktrup, L., West, C.
Format Journal Article
LanguageEnglish
Published 01.04.2021
Online AccessGet full text

Cover

More Information
ISSN:1063-4584
DOI:10.1016/j.joca.2021.02.328